Healthcare · Pharmaceutical market size
Papua New Guinea's pharmaceutical market is valued at 300 M $ (2026), placing it 112th out of 197. The country relies almost entirely on imported medicines, with local production limited to a few repackaging facilities. Key suppliers include Australia, India, and China. High logistics costs and poor distribution to remote highland areas make medicines inaccessible for much of the population.
Data for 2026 · unit: $
Position
#112 / 197
Papua New Guinea world ranking
Country position on the scale from last to first place for this indicator.
PG
#112
#197#1
Trend
Change over time
Change in indicator over the available period.
1 M
1950
30 M
1990
50 M
2000
150 M
2010
300 M
2020
300 M
2025
300 M
2026
Values — $
Comparison
Top countries by Pharmaceutical market size
Where Papua New Guinea stands in the world ranking.
1
USUSA
500 B
2
CNChina
250 B
3
JPJapan
110 B
4
DEGermany
75 B
5
BRBrazil
60 B
5
INIndia
60 B
7
GBUnited Kingdom
45 B
8
ITItaly
43 B
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical market size in Papua New Guinea — how much?
Based on 2026 data — 300 M $. This is rank #112 out of 197 countries.
What is Papua New Guinea's rank by Pharmaceutical market size?
Papua New Guinea ranks #112 out of 197 countries in the world ranking by «Pharmaceutical market size».
How has Pharmaceutical market size changed in Papua New Guinea?
Over the available period the indicator changed from 1 M to 300 M $.